Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study—TROG 18.06

PURPOSE: The O-(2-[(18)F]-fluoroethyl)-l-tyrosine (FET) PET in Glioblastoma (FIG) trial is an Australian prospective, multi-centre study evaluating FET PET for glioblastoma patient management. FET PET imaging timepoints are pre-chemoradiotherapy (FET1), 1-month post-chemoradiotherapy (FET2), and at...

Descripción completa

Detalles Bibliográficos
Autores principales: Barry, Nathaniel, Francis, Roslyn J., Ebert, Martin A., Koh, Eng-Siew, Rowshanfarzad, Pejman, Hassan, Ghulam Mubashar, Kendrick, Jake, Gan, Hui K., Lee, Sze T., Lau, Eddie, Moffat, Bradford A., Fitt, Greg, Moore, Alisha, Thomas, Paul, Pattison, David A., Akhurst, Tim, Alipour, Ramin, Thomas, Elizabeth L., Hsiao, Edward, Schembri, Geoffrey P., Lin, Peter, Ly, Tam, Yap, June, Kirkwood, Ian, Vallat, Wilson, Khan, Shahroz, Krishna, Dayanethee, Ngai, Stanley, Yu, Chris, Beuzeville, Scott, Yeow, Tow C., Bailey, Dale, Cook, Olivia, Whitehead, Angela, Dykyj, Rachael, Rossi, Alana, Grose, Andrew, Scott, Andrew M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611835/
https://www.ncbi.nlm.nih.gov/pubmed/37563351
http://dx.doi.org/10.1007/s00259-023-06371-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611835/
https://www.ncbi.nlm.nih.gov/pubmed/37563351
http://dx.doi.org/10.1007/s00259-023-06371-5

Ejemplares similares